Compare RNA & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | RFIL |
|---|---|---|
| Founded | 2012 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.5M | 191.3M |
| IPO Year | 2025 | 1996 |
| Metric | RNA | RFIL |
|---|---|---|
| Price | $11.92 | $13.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 1 |
| Target Price | ★ $69.26 | $11.25 |
| AVG Volume (30 Days) | 229.2K | ★ 415.3K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 101.59 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $55,325,000.00 |
| Revenue This Year | $88.12 | $9.65 |
| Revenue Next Year | $18.11 | $6.40 |
| P/E Ratio | ★ N/A | $186.14 |
| Revenue Growth | N/A | ★ 10.22 |
| 52 Week Low | $11.40 | $5.54 |
| 52 Week High | $73.06 | $22.30 |
| Indicator | RNA | RFIL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.